• Extend | Exchange | Excite!

Thank you for attending the 2014 NIRI Annual Conference

Sessions

Patrick Flanigan

Investor Relations
Celgene

Biography

Patrick E. Flanigan III has over 16 years equity capital markets experience serving as both an Investor Relations Officer at two of the largest global biopharmaceutical companies and a senior equity research analyst covering the biotechnology sector at leading emerging growth investment banks . He has organized over a dozen Analyst Days and attended almost 100 analyst events during this timeframe. Mr. Flanigan is currently Vice President of Investor Relations at Celgene Corporation. Previously, he was Vice President at Genzyme Corporation. During seven years of leading the Investor Relations function, he has developed in-depth experience in crises communications, proxy contests with leading activists, and unsolicited tender offers. Prior to investor relations, Mr. Flanigan conducted equity research for Cowen & Company, Canaccord Genuity (formerly Adams, Harkness & Hill), and W.R. Hambrecht+Co.

© Copyright 2014 National Investor Relations Institute (NIRI)